首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1819743

欧洲解剖病理学市场报告 2021-2031（范围、细分、动态和竞争分析）

Europe Anatomic Pathology Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: 2025年07月10日 | 出版商:

The Insight Partners | 英文 134 Pages | 订单完成后即时交付

价格

简介目录图表

解剖病理学市场预计将大幅成长，到 2031 年将达到约 149.9993 亿美元，高于 2023 年的 84.6165 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 7.4%。

执行摘要和欧洲市场概览

在欧洲，解剖病理学市场主要分布在几个主要国家，包括德国、法国、英国、义大利、西班牙和其他地区。欧洲该市场的成长主要得益于癌症发生率的上升，尤其是子宫颈癌和乳癌。此外，卫生当局实施的各种癌症筛检计画旨在降低慢性病的盛行率，预计将为市场创造进一步的成长机会。

市场区隔分析

欧洲解剖病理学市场可以透过几个部分进行分析：产品和服务、应用和最终用户。

1. 产品与服务：市场分为服务、仪器和耗材。 2023年，仪器占据了最大的市场。服务细分市场进一步分为组织病理学和细胞病理学，而仪器细分市场包括切片机、低温恆温器、自动染色机、组织处理机和其他相关工具。

2. 应用：市场根据应用细分为疾病诊断、药物研发和其他领域。疾病诊断领域在2023年占据最大份额，反映了解剖病理学在识别各种疾病方面的关键作用。

3. 最终使用者：最终使用者细分包括医院、研究实验室、诊断实验室等。医院在2023年占据了最大的市场份额，凸显了其在疾病诊断和治疗中的核心作用。

市场展望

解剖病理学在诊断各种疾病（包括自体免疫疾病、肾臟和肝臟疾病以及癌症）中起着至关重要的作用。组织病理学专注于检查疾病引起的组织变化，在癌症诊断中尤其重要。癌症仍然是全球面临的重大健康挑战，也是全球主要死亡原因之一。世界卫生组织 (WHO) 将癌症列为全球第二大死因。 2022 年，全球报告新增癌症病例约 2,000 万例，2020 年癌症死亡人数近 1,000 万人。光是在英国，每年就有约 392,000 例新发癌症病例，约 167,000 人死于癌症。

人口老化导致慢性肾臟病患病率上升，进一步凸显了活检等解剖病理学技术在检测癌症和肾臟疾病的重要性。随着癌症和其他慢性疾病发生率的上升，医疗保健提供者、政府机构和机构越来越重视加强疾病的诊断和治疗。这一趋势预计将推动欧洲解剖病理学市场的成长。

特定国家的见解

欧洲解剖病理学市场主要包括英国、德国、法国、义大利、西班牙等国家。 2023年，德国占了最大的市场份额，这主要归功于细胞学检查的广泛认可，尤其是在子宫颈癌筛检计画中。德国政府一直积极改善医疗基础设施，特别是透过其子宫颈癌筛检计画。该计画于2020年1月进行了更新，将35岁及以上女性每三年进行一次细胞学和人类乳突病毒(HPV)联合检测纳入其中。

子宫颈癌病例的增加促使德国各地纷纷推行筛检措施。近期研究表明，细胞学检查仍然是子宫颈癌筛检的重要组成部分，大规模进行高风险HPV初次筛检或有助于最终消除子宫颈癌。德国众多知名研究机构的存在也促进了旨在早期发现和预防疾病的创新病理学检测的发展。例如，科隆病理研究所每年处理约4万份手术标本，并进行150次尸检，彰显了德国强大的病理学服务。

公司简介

欧洲解剖病理学市场的主要参与者包括罗氏公司 (F. Hoffmann-La Roche Ltd)、贝克曼库尔特公司 (Beckman Coulter Inc)、豪洛捷公司 (Hologic Inc)、安捷伦科技公司 (Agilent Technologies Inc)、Diapath SpA、Bio SB、默克公司 (Merck KGaA) 和 PHC Holdings Corporation 等。这些公司正在采用各种策略，包括市场扩张、产品创新和併购，以增强其产品组合併提高其市场占有率。

总之，受癌症和慢性病发病率上升以及医疗技术和筛检措施不断进步的推动，欧洲解剖病理学市场有望大幅成长。

In Europe, the anatomic pathology market is divided into several key countries, including Germany, France, the UK, Italy, Spain, and other regions. The growth of this market in Europe is primarily driven by the increasing incidence of cancers, particularly cervical and breast cancer. Additionally, various cancer screening initiatives implemented by health authorities aim to lower the prevalence of chronic diseases, which is expected to create further growth opportunities in the market.

Market Segmentation Analysis

The European anatomic pathology market can be analyzed through several segments: products and services, applications, and end users.

1. Products and Services: The market is categorized into services, instruments, and consumables. In 2023, instruments accounted for the largest market share. The services segment is further divided into histopathology and cytopathology, while the instruments segment includes microtomes, cryostats, automatic stainers, tissue processors, and other related tools.

2. Applications: The market is segmented based on applications into disease diagnosis, drug discovery and development, and other areas. The disease diagnosis segment held the largest share in 2023, reflecting the critical role of anatomic pathology in identifying various diseases.

3. End Users: The end-user segmentation includes hospitals, research laboratories, diagnostic laboratories, and others. Hospitals represented the largest share of the market in 2023, highlighting their central role in disease diagnosis and treatment.

Market Outlook

Anatomic pathology plays a crucial role in diagnosing various diseases, including autoimmune disorders, kidney and liver diseases, and cancers. Histopathology, which focuses on examining tissue changes due to diseases, is particularly vital in cancer diagnosis. Cancer remains a significant global health challenge, being one of the leading causes of death worldwide. The World Health Organization (WHO) identifies cancer as the second leading cause of mortality globally. In 2022, approximately 20 million new cancer cases were reported, and nearly 10 million deaths were attributed to cancer in 2020. In the UK alone, around 392,000 new cancer diagnoses occur annually, with approximately 167,000 deaths each year due to the disease.

The rising prevalence of chronic kidney disease, driven by an aging population, further emphasizes the importance of anatomic pathology techniques such as biopsies for detecting cancer and kidney diseases. As the incidence of cancer and other chronic diseases rises, healthcare providers, government agencies, and institutions are increasingly focused on enhancing disease diagnosis and treatment initiatives. This trend is expected to propel the growth of the anatomic pathology market in Europe.

Country-Specific Insights

The European anatomic pathology market includes key countries such as the UK, Germany, France, Italy, Spain, and others. Germany held the largest market share in 2023, largely due to the significant recognition of cytology, especially in relation to cervical cancer screening programs. The German government has been proactive in improving medical infrastructure, particularly through its cervical cancer screening program, which was updated in January 2020 to include co-testing for cytology and human papillomavirus (HPV) every three years for women aged 35 and older.

The increase in cervical cancer cases has led to a rise in screening initiatives across Germany. Recent studies indicate that cytology remains a critical component of cervical cancer screening, and the implementation of mass primary high-risk HPV screening may contribute to the eventual elimination of cervical cancer. The presence of esteemed research institutions in Germany also supports the advancement of innovative pathology tests aimed at early disease detection and prevention. For instance, the Institute for Pathology in Cologne processes around 40,000 surgical specimens and conducts 150 postmortems annually, underscoring the robust pathology services available in the country.

Company Profiles

Key players in the European anatomic pathology market include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

In conclusion, the European anatomic pathology market is poised for substantial growth, driven by the rising prevalence of cancer and chronic diseases, alongside ongoing advancements in medical technology and screening initiatives.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Anatomic Pathology Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Anatomic Pathology Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Prevalence of Cancer and Kidney Diseases
- 5.1.2 Rise in Number of Strategic Initiatives
5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.2.2 Stringent Government Regulations
5.3 Market Opportunities
- 5.3.1 Growing Focus on Personalized Medicines
5.4 Future Trends
- 5.4.1 Integration of Artificial Intelligence and Machine Learning
5.5 Impact of Drivers and Restraints:

6. Anatomic Pathology Market - Europe Analysis

6.1 Europe Anatomic Pathology Market Revenue (US$ Million), 2021-2031
6.2 Europe Anatomic Pathology Market Forecast Analysis

7. Europe Anatomic Pathology Market Analysis - by Product and Services

7.1 Services
- 7.1.1 Overview
- 7.1.2 Services: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Consumables
- 7.3.1 Overview
- 7.3.2 Consumables: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Anatomic Pathology Market Analysis - by Application

8.1 Disease Diagnosis
- 8.1.1 Overview
- 8.1.2 Disease Diagnosis: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Drug Discovery and Development
- 8.2.1 Overview
- 8.2.2 Drug Discovery and Development: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Anatomic Pathology Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Research Laboratories
- 9.2.1 Overview
- 9.2.2 Research Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Diagnostic Laboratories
- 9.3.1 Overview
- 9.3.2 Diagnostic Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Anatomic Pathology Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Anatomic Pathology Market Overview
- 10.1.2 Europe Anatomic Pathology Market - Revenue and Forecast Analysis - by Country
  - 10.1.2.1 United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.1.1.1 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.1.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.1.2 United Kingdom: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.1.3 United Kingdom: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.2 Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.2.1 Germany: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.2.1.1 Germany: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.2.1.2 Germany: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.2.2 Germany: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.2.3 Germany: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.3 France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.3.1 France: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.3.1.1 France: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.3.1.2 France: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.3.2 France: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.3.3 France: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.4 Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.4.1 Italy: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.4.1.1 Italy: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.4.1.2 Italy: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.4.2 Italy: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.4.3 Italy: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.5 Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.5.1 Spain: Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.5.1.1 Spain: Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.5.1.2 Spain: Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.5.2 Spain: Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.5.3 Spain: Europe Anatomic Pathology Market Breakdown, by End User
  - 10.1.2.6 Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.2.6.1 Rest of Europe Anatomic Pathology Market Breakdown, by Product and Services
      - 10.1.2.6.1.1 Rest of Europe Anatomic Pathology Market Breakdown, by Services
      - 10.1.2.6.1.2 Rest of Europe Anatomic Pathology Market Breakdown, by Instruments
    - 10.1.2.6.2 Rest of Europe Anatomic Pathology Market Breakdown, by Application
    - 10.1.2.6.3 Rest of Europe Anatomic Pathology Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Europe Anatomic Pathology Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Beckman Coulter Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Hologic Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Agilent Technologies Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Diapath S.p.A.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Bio SB
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Merck KGaA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 PHC Holdings Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Anatomic Pathology Market Segmentation
Table 2. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Product and Services
Table 4. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 5. Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 6. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 7. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 8. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 9. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 11. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 12. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 13. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 14. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 15. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 16. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 17. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 18. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 19. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 20. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 21. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 22. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 23. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 24. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 25. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 26. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 27. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 28. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 29. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 30. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 31. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Product and Services
Table 32. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Services
Table 33. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
Table 34. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 35. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million) - by End User
Table 36. Recent Organic Growth Strategies in Europe Anatomic Pathology Market
Table 37. Recent Inorganic Growth Strategies in the Europe Anatomic Pathology Market
Table 38. Glossary of Terms, Anatomic Pathology Market

List Of Figures

Figure 1. Europe Anatomic Pathology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Europe Anatomic Pathology Market - Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Anatomic Pathology Market Revenue (US$ Million), 2021-2031
Figure 6. Europe Anatomic Pathology Market Share (%) - by Product and Services (2023 and 2031)
Figure 7. Services: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Instruments: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Consumables: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Europe Anatomic Pathology Market Share (%) - by Application (2023 and 2031)
Figure 11. Disease Diagnosis: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Drug Discovery and Development: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Europe Anatomic Pathology Market Share (%) - by End User (2023 and 2031)
Figure 15. Hospitals: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Research Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Others: Europe Anatomic Pathology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Europe Anatomic Pathology Market Breakdown, by Key Countries - Revenue (2023) (US$ Million)
Figure 20. Europe Anatomic Pathology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 21. United Kingdom: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Germany: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. France: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Italy: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 25. Spain: Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 26. Rest of Europe Anatomic Pathology Market - Revenue and Forecast to 2031(US$ Million)
Figure 27. Growth Strategies in Europe Anatomic Pathology Market